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Abstract

Patients on antipsychotic medications are at higher risk of developing metabolic syndrome;
nevertheless, metabolic screening for patients on antipsychotics is suboptimal. This project
implemented a nurse-driven protocol on inpatient psychiatric units to increase metabolic screening
compliance rates. The literature on improving metabolic screening as well as the clinical use of
nurse-driven protocols were used to develop a protocol. The initial implementation of the protocol
showed no change in screening rate; however, when the protocol was updated to include nursing
leader involvement, metabolic screening increased. Nurses’ perception of the nurse-driven
protocol was examined and found a negative perception and no change in empowerment when
nurses were surveyed pre- and post-implementation. Further research is needed to better
understand adoptability of nurse-driven protocols in the psychiatric inpatient setting as well as
other applications, such as smoking cessation or safety sitters.
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Chapter One
Introduction
Metabolic syndrome is a cluster of risk factors that includes diabetes and prediabetes,
abdominal obesity, plus high cholesterol and other unhealthy lipids. Patients with metabolic
syndrome also suffer from high blood pressure at increased rates, which places them at twice the
risk for death, three times the risk of heart attack or stroke and five times the risk of developing
type 2 diabetes when compared with the general population (International Diabetes Federation,
2007). Multiple studies have shown an association with increased or worsening metabolic
syndrome and the use of antipsychotic medication (Centorrino et al., 2012; Rojo et al., 2015;
Vancampfort et al., 2015). In February 2004, the American Diabetes Association, in conjunction
with the American Psychiatric Association, the American Association of Clinical
Endocrinologists, and the North American Association for the Study of Obesity, published a
consensus statement on the association of antipsychotic drugs and metabolic risks as well as
recommendations to help screen for these risks (American Diabetes Association et al., 2004). In
2016, the Centers for Medicare and Medicaid Services (CMS) incorporated metabolic screening
for patients on antipsychotic medication in their Inpatient Psychiatric Facility Quality Reporting
Program.
Metabolic screening should occur early and often in order to evaluate the risk to the patient
compared to the therapeutic benefits of the antipsychotic medication. Screening should help
determine if a switch in antipsychotic medication is needed, since different medications have
varying risk of metabolic syndrome (Hasnain et al., 2010; Meyer & Koro, 2004; Papanastasiou,
2013). Effective screening can also help the interdisciplinary team provide more focused
interventions and teaching, including smoking cessation, dietary measures, exercise, and

pharmacologic management of metabolic syndrome (Mitchell et al., 2013). In addition to the
medical issues associated with antipsychotic medication, metabolic screening could also assist
with medication compliance. Nonadherence to antipsychotic drugs is associated with a higher rate
of positive and negative psychotic symptoms and a greater risk of hospital readmission (Mutsatsa
et al., 2003; Verdoux et al., 2000). Weight gain associated with antipsychotic medication has been
found to be one of the main reasons patients stop taking these medications leading to
noncompliance (Perkins, 2002; Weiden et al., 2004).
Despite evidence of the possible risks and the actions of multiple healthcare bodies,
screening for metabolic syndrome remains at suboptimal levels for patients taking antipsychotic
medications. Morrato et al. (2009) found that of the over eighteen thousand adult patients on
antipsychotics, only 23% had glucose levels tested and 8% had lipid levels tested in the United
States. In their meta-analysis of thirty-nine studies with over two hundred thousand patient records
in five countries, including the United States, Mitchell et al. (2012) found baseline screening rates
for general lipid monitoring was 22.2% and Hemoglobin A1C was 16.0% for records with
antipsychotic use.

Problem Statement
Given the established importance yet lack of satisfactory metabolic screening for
patients taking antipsychotic medications, this project proposes the use of a nurse-driven
protocol to increase compliance to screening guidelines in the inpatient psychiatric setting.
Multiple studies show that nurse-driven protocols can improve patients’ clinical outcomes in
different settings. The hallmark use of nurse-driven protocols is for the removal of urinary
catheters on medical inpatient units, with numerous studies demonstrating a post-protocol
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reduction in catheter-associated urinary tract infections (Durant, 2017). Further research
supports the use of nurse-driven protocols related to other clinical outcomes including
increased accuracy and outcomes of sepsis screening (Alberto et al., 2017), decreased
personnel cost through the use of video monitoring (Burtson & Vento, 2015), improved alcohol
withdrawal management (Ycaza-Gutierrez et al., 2015), improved mobility and decreased
length of stay by using early progressive mobility in intensive care units (Klein et al., 2018),
and fewer ventilation days due to decreased use of sedation (Kaplan et al., 2019).
This DNP project will develop and implement a model nurse-driven protocol to prevent
and reduce metabolic syndrome in the mental health inpatient population on antipsychotic
medications. It will include thorough metabolic screening for the following indices: blood
pressure, body mass index (BMI), lipid levels, and glucose levels. It will also include nurse
led patient education and follow-up care with referrals for treatment of metabolic syndrome.

Significance of Addressing the Problem

Multiple studies have shown an association with increased or worsening metabolic
syndrome and the use of antipsychotics (Centorrino et al., 2012; Rojo et al., 2015; Vancampfort et
al., 2015). The prevalence of metabolic syndrome in patients with psychotic disorders varies
largely (3.9–68%) but it is at least five times higher compared to matched healthy control groups
(Papanastasiou, 2013). Screening for metabolic syndrome remains suboptimal for patients taking
antipsychotic medications.
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Chapter Two
Review of Literature
Search Strategy
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Medline
databases were used to search the literature. The following search terms were used: nurse driven
protocol, [barrier, adherence, compliance, or fidelity], [perception, attitude, response, or opinion],
[empowerment, self-efficacy, autonomy, job satisfaction, or engagement], metabolic [screening or
syndrome], antipsychotic*, or inpatient [mental health, behavioral, or psychiatry]. Only articles
published in English were included. Qualitative and quantitative studies that addressed staff’s
perception or opinion on nurse-driven protocols were included. Studies that focused on nursedriven protocols’ effect on clinical outcomes were included, only if they addressed the staff’s
perception on the use of the nurse-driven protocols in some form. Articles were not excluded based
on setting or publication date. Appendix A shows the adapted Preferred Reporting Items for
Systemic Reviews and Meta-Analyses (adapted PRISMA).
The search found articles with varying topics related to metabolic screening and nursedriven protocols: barriers to metabolic screening, interventions to improve metabolic screening,
interventions to improve metabolic syndrome, and nurse-driven protocol perception.

Barriers to Metabolic Screening
One of the common barriers cited in the literature on antipsychotic related metabolic
syndrome is the uncertainty of who is responsible for screening patients on antipsychotic
medications (Hasnain et al., 2010). Most United States psychiatrists (94% of surveyed physicians)
believe that monitoring for metabolic syndrome is important for patients on antipsychotic
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medication; however, the study showed that fewer psychiatrists performed the screening: 69%
reported monitoring glucose, 61% lipids, and 52% blood pressure (Suppes et al., 2007). A literature
review on the topic found themes in four articles that physicians report metabolic screening to be
a low priority (Chee et al., 2017). Earlier research suggested that there was no consensus on which
specialty is responsible for metabolic screening, for example, primary care or psychiatry
(Mangurian et al., 2013). However, more recent literature shows that there has been a movement
towards placing the responsibility on psychiatric practitioners. In 2016, Laugharne et al. reported
that more than 80% of surveyed psychiatric fellows felt it was the psychiatrist’s responsibility to
ensure that metabolic screening was done. Furthermore, six years after their initial survey,
Mangurian et al. (2019) found that primary care providers and psychiatrists agreed that metabolic
screening should be completed by mental health workers. Other cited barriers included no
established guidelines or clinical reminders at the work place (Laugharne et al., 2016) and limited
resources or tools to complete screenings (Melamed et al., 2019).

Interventions to Improve Metabolic Screening
Most interventions used to improve metabolic screening compliance take place with the
providers, patients, or system (Melamed et al., 2021; Melamed et al., 2019). For physicians, studies
show an increase in metabolic screening compliance with clinical reminders and provider
education on the syndrome itself (Melamed et al., 2019). For patients, four studies in Melamed et
al. (2019)’s literature review show a theme of an increase in screening when patients are
empowered to seek out the screening with education and encouragement. Lastly, at a systems level,
studies show that screening compliance increased with engaged leadership, who were aware of the
side effects and promoted physical wellness (Melamed et al., 2021; Melamed et al., 2019). Most
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studies attempted to change the organizational culture to promote metabolic screening through the
use of social influence: frontline champions, active support and adherence monitoring from
administrative service leaders, and shared benchmarked performance audits for metabolic risk
screening within their services (Melamed et al., 2021; Melamed et al., 2019). In their systematic
review, Melamed et al. (2019) found that most interventions used were able to increase metabolic
screening rates: median metabolic screening rates for glucose (28% to 65%), lipids (22% to 61%),
weight (19% to 67%), and BP (22% to 80%). However, screening remained suboptimal; on
average, up to one-third of patients still went unscreened (Melamed et al., 2019).
Nursing
Few studies focus on the use of nursing professionals to increase metabolic screening rates
yet mental health nurses are the ideal candidates to take on the responsibility for enhanced
screening. Nurses are trained in both medical and mental health skills, trained to advocate for
vulnerable populations, and to educate on medication side effects, as well as to collaborate and
communicate with multiple disciplinary teams (Chee et al., 2017). In their study, Hibner et al.
(2020) developed a pharmacist-and nurse-driven protocol in the outpatient mental health clinic
setting and found an increase in Hemoglobin A1C (27.5% to 42.5%, p = 0.044) and lipid level
(17.5% to 31.3%, p = 0.04) after implementation. Peh (2008) increased to 100% metabolic
screening compliance within three months after a multifaceted intervention; the study included
nursing responsibility for blood tests and measurements for physicians who had reported time
restrictions.
Furthermore, Osborn et al. (2010) added a nurse-led intervention, where nurses with
experience in providing cardiovascular screening would monitor whether screening had occurred
on patients with severe mental health illness (SMI) being followed by a community mental health
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team. If it had not, the nurse could send reminders to staff or perform the screening herself,
including obtaining laboratory tests (non-fasting serum levels of cholesterol, high density
lipoprotein cholesterol, and random glucose). Osborn et al. (2010) found a 30% increase in
metabolic screening for those with SMI, specifically for the following indices: blood pressure
(96% vs. 68%, OR 13.6), cholesterol (66.7% vs. 29%, OR 6.1), glucose (66.7% vs 36.5%, OR
4.4), and BMI (92.5% vs 65.2%, OR 6.5).

Interventions to Improve Metabolic Syndrome
Increasing compliance of metabolic screening is only useful if followed by appropriate
interventions. The most common intervention relates to lifestyle changes, for example education
or motivational counseling for nutrition/dietary or exercise changes (De Hert et al., 2011; Hasnain
et al., 2010). Medication changes can be considered following positive screening, since some
antipsychotic medication (Abilify or Geodon) have lower metabolic risk than others (Zyprexa or
Clozaril) (De Hert et al., 2011; Hasnain et al., 2010). Lastly, though not directly related to the
medication and its side effect, smoking cessation in patients with metabolic syndrome is highly
encouraged due to smoking’s high prevalence in the mental health population and its effect on
cardiovascular and metabolic dysregulation (Hasnain et al., 2010; Melamed et al., 2019).
Pharmacological intervention can also be considered when treating metabolic syndrome
associated with antipsychotic medications. Metformin for weight gain and blood sugar
dysregulation and statins for dyslipidemia have been shown to help patients with metabolic
syndrome (De Hert et al., 2011; Hasnain et al., 2010). However, psychiatrists are reluctant to
prescribe these types of medications (Mangurian et al., 2019)
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Nurse-driven Protocol Perception
A nurse-driven protocol is a rubric, allowing nurses to make decisions related to a patients’
care, treatment, and/or services without referring to a physician or other independently licensed
practitioners; the protocol should also include the circumstances in which the protocols may be
used and the details of the procedures involved (The Joint Commission, 2013). Multiple studies
show that nurse-driven protocols can improve patients’ clinical outcomes in different settings. The
hallmark use of nurse-driven protocols is for the removal of urinary catheters on medical inpatient
units, with numerous studies demonstrating a post-protocol reduction in catheter-associated
urinary tract infections (Durant, 2017).
This review of literature focuses on the staff perception of nurse-driven protocols related
to various clinical outcomes in various settings found in eight studies. Only one study examined
staff perception and clinical outcomes: Gunther et al. (2021) implemented a registered nurse- and
respiratory therapist-driven mechanical ventilation weaning protocol in a medical ICU and found
that patients under the protocol had significantly lower duration of mechanical ventilation (74 vs
152 hours; P = .002) and shorter ICU length of stay (6.7 vs 10.2 days; P = .031). The other seven
studies only examined the perception of staff on the following nurse-driven protocols: Beck and
Johnson (2008) on a nurse-driven sedation protocol in the intensive care unit (ICU), Blodgett and
Sheets (2021) and Olson-Sitki et al. (2015) on a nurse-driven catheter removal protocol on various
units in an acute hospital setting, Fry et al. (2009) on a nursing-driven protocol for sedation and
analgesia on a burn-trauma ICU, Smith et al. (2007) on a nurse-driven insulin infusion protocol in
an ICU, Tume et al. (2014) on a nurse-led ventilation weaning in a pediatric ICU, and YcazaGutierrez et al. (2015) on a nurse-driven protocol for management of alcohol/polysubstance abuse
withdrawal in a medical ICU.
8

Nursing Perception of Use
Seven of the studies focused on the nursing perception of use: ease and comfortability
(Beck & Johnson, 2008; Blodgett & Sheets, 2021; Fry et al., 2009; Gunther et al., 2021; OlsonSitki et al., 2015; Smith et al., 2007; Ycaza-Gutierrez et al., 2015). Olson-Sitki et al. (2015) and
Smith et al. (2007) both found that nurses reported a high rate of ease when surveying the
perception of nurse-driven protocols. However, in their open-ended questions, Olson-Sitki et al.
(2015) found a theme of nurses reporting a lack of comfortability with use of the protocols. Beck
& Johnson (2008) found that nurses thought nurse-driven protocols were not easy and nurses
lacked confidence in use. On the other hand, Fry et al. (2009), Gunther et al. (2021), and Beck &
Johnson (2008) discovered that nurses reported feeling comfortable and/or confident with the use
of nurse-driven protocols. Ycaza-Gutierrez et al. (2015) reported a decrease in anxiety with
treating patients after the implementation of a nurse-driven protocol. Blodgett and Sheets (2021)
found that nurses agreed that a nurse-driven protocol was an acceptable intervention for preventing
harm, helpful for their patient, and that they would approve its use on a loved one; however, the
nurses also felt that the risk for harm did not justify the use of a nurse-driven protocol and its
potential side effects.
Nursing Perception of Autonomy and Empowerment
Four studies surveyed nurses on their perception of autonomy and empowerment related
to nurse-driven protocols with varying findings (Beck & Johnson, 2008; Gunther et al., 2021;
Olson-Sitki et al., 2015; Tume et al., 2014). Olson-Sitki et al. (2015) found that nurses felt that
nurse-driven protocols were empowering, regardless if the nurses had used a nurse-driven
protocols or not but nurse-driven protocols had no effect on job satisfaction. Olson-Sitki et al.
(2015) and Gunther et al. (2021) found a theme of increased nursing autonomy when using their
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respective protocols. However, Beck & Johnson (2008) found that nurse-driven protocols had no
effect on nurses’ perception of autonomy and Tume et al. (2014) cited nurses’ reports that nursedriven protocols limited their autonomy.
Nursing Perception based on Demographics
Three studies found correlations between demographics, particularly years of experience,
and nursing perception of nurse-driven protocols (Fry et al., 2009; Olson-Sitki et al., 2015; Tume
et al., 2014). There was a negative correlation between nurses’ years of experience and reporting
the use of nurse-driven protocols, showing nurses with more years of experience not using the
protocols (Fry et al., 2009; Olson-Sitki et al., 2015). Olson-Sitki et al. (2015) also reported a
negative correlation between nurses’ age and years working at the current hospital and reporting
the use of nurse-driven protocols. Fry et al. (2009) also found that nurses with more experience
were less likely to support the creation and use of nurse-driven protocols. In discussing their
findings, Fry et al. (2009) suggested that nurses with more experience are less familiar with what
nurse-driven protocols are, how to use them, and the research supporting them. On the other hand,
Tume et al. (2014) found that nurses with less experience felt that nurse-driven protocols added to
their workload and had a greater fear of negative clinical outcomes from using nurse-driven
protocols. Tume et al. (2014) suggest that nurses with less experience are less likely to be able to
prioritize and manage one’s workload and have less confidence in their interventions.

Summary of Literature Findings
Overall, there are multiple barriers to developing a nurse-driven protocol for metabolic
screening. One of the main noted challenges in the literature is who takes on the responsibility,
which a nurse-driven protocol would place the responsibility of metabolic screening on mental
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health nurses. Furthermore, the literature shows a mixed perception of nurse-driven protocols in
the inpatient setting, which would need to be addressed for the protocol to be effective towards
better outcomes. More complete information on all the studies included in this review can be found
in the Evidence Matrix (Appendix B).

Project Model
The change model used for this project will be based on Rosswurm and Larrabee’s revised
Model for Evidence-Based Practice Change (Larrabee, 2004; Rosswurm & Larrabee, 1999). The
model is shown in Appendix C and is broken down into six steps: assessment of need, location of
best evidence, analyzation of evidence, design of practice change, implementation and evaluation
of change, and integration and maintenance of change. First, there will be an assessment of need
for change in practice, where a problem or area for improvement in practice will be identified.
Second, through the use of literature review and experts, the best evidence will be located. Third,
the evidence will be critically analyzed and appraised; it will be judged based on its strength as
well as its feasibility, benefits, and risks. Fourth, from the best evidence, a practice change will be
designed, as well as the implementation and evaluation plans. Fifth, the change in practice will be
implemented and evaluated. The process, outcomes, and cost will be evaluated and conclusions
and recommendations will be developed. Sixth and last, the change in practice will be integrated
into standards of care and maintained through monitoring the process and outcomes as well as
celebrating and disseminating results.
In this project, first, compliance rates for metabolic screening were examined and the need
for improvement was determined. Second, a literature review was conducted and best practices for
improvement were examined and incorporated into the development of a nurse-driven protocol.

11

Third, the research and the protocol were critically analyzed by stakeholders at the hospitals as
well as by an expert panel. Fourth, a nurse-driven protocol was finalized and a roll-out plan for
this implementation was made. Fifth, the protocol was implemented on multiple units and the
outcomes were evaluated by compliance rates. Sixth, the protocol, implementation, and outcomes
were presented to the larger hospital systems for scaling and maintaining. Chapter 3 describes
these steps in more detail.

Theoretical Framework
This project utilized Sieloff’s theory of work team empowerment (Sieloff, 1996; Sieloff &
Bularzik, 2011) as a supporting theoretical framework. This middle range nursing theory was
developed from King’s (1981) conceptual system framework and suggests that group
empowerment occurs when nurses achieve their goals, usually related to patient outcomes. The
common goal for the pilot nursing group was the improvement in rates of metabolic screening in
the patient population, with which they work. The theory advocates that a group of nurses can be
empowered without taking power from another group, so by taking on a larger role in metabolic
screening, nursing will not be taking any power or responsibility from other members of the
interdisciplinary team. The theory views power as solely a positive resource to assist nurses in
attaining goals and thus power should be sought out by the group. Nurses who feel empowered
report higher levels of quality in their patient care (Laschinger et al., 2001; Laschinger, 2008). By
expanding nurses’ role in the metabolic screening process and working towards a common goal,
the nurse-driven protocol can empower nurses and improve patient care.
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Organizational Analysis
The project was initiated on units at separate hospitals in the same health system. The health
system is a large, stand-alone, not-for profit, psychiatric hospital system located in the midAtlantic region of the United States. The hospital has approximately 270 inpatient beds with
multiple specialized inpatient psychiatric units. A SWOT analysis was performed (see Appendix
D).
Strengths
The hospital has multiple resources dedicated to mental health. It has strong brand recognition and
attracts patients from across the country for its specialty programs. It has a strong emphasis on
research with a Center of Excellence. The hospital is also expanding services to meet the needs of
the community and its units have a high nurse to patient ratio.
Weaknesses
The hospital has high nurse turnover and lacks any formal nursing empowerment programs.
Nursing recognition is infrequent. There is little to no nursing research and it does not use nursedriven protocols currently.
Opportunities
The hospital has good collaboration with neighboring acute care hospital for referrals and
contracted services. It is consistently ranked as a top ten national psychiatric hospital by U.S. News
& World Report for 30 years.
Threats
The hospital has salaries below market and has competition with acute care hospitals for staff. It
currently has low publicly reported Centers for Medicare & Medicaid Services’ psychiatric quality
measures. It also is a state safety net hospital for mental health, receiving some of the most difficult
patients with mental health disorders in the state.
13

Project Aims
This DNP project developed and implemented a model nurse-driven protocol to prevent
and reduce metabolic syndrome in the mental health inpatient population on antipsychotic
medications. The overall goal of this project was to improve the rates of metabolic screening on
patients on antipsychotic medication in the inpatient mental health setting. It also examined the
effects of the nurse-driven protocol on the use of the screening information to improve metabolic
syndrome symptoms as well as its effects on nursing empowerment and nursing perception. The
project will serve as a model to be assessed for scaling and implementation in other inpatient
mental health units in the health system.
1. To develop a model nurse-driven protocol for metabolic screening and education of
inpatients on antipsychotic medication
2. To implement and evaluate the nurse-driven protocol for metabolic screening
3. To make recommendations for sustainability and scaling of the nurse-driven protocol for
metabolic screening at the corporate systems level
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Chapter Three
Approach to Aims
This quality improvement project developed and implemented a model nurse-driven
protocol to prevent and reduce metabolic syndrome in a mental health inpatient population on
antipsychotic medications. It was implemented on two different units and pre- and postintervention compliance rates were compared. The project then assessed sustainability and scaling
to multiple other mental health inpatient units. The project aims and methods are described in
further detail in this chapter.

Aim 1: To develop a model nurse-driven protocol for metabolic screening and education of
inpatients on antipsychotic medication
The project started by gathering data on metabolic screening for two inpatient psychiatric
units via chart audits. Chart audits were completed automatically by nurse unit managers and the
investigator. CMS’s definition of compliance rates for metabolic screening were used. CMS
calculates screening for metabolic disorders as the percentage of patients discharged from an
Inpatient Psychiatric Facility (IPF) with a prescription for one or more routinely scheduled
antipsychotic medications for which a structured metabolic screening for four elements was
completed in the 12 months prior to discharge either prior to or during the IPF stay. The four
elements of the metabolic screening are blood pressure, BMI, lipid levels, and glucose levels. The
numerator is the total number of patients who received a metabolic screening in the 12 months
prior to discharge and the denominator is the number of patients discharged with a prescription for
one or more routinely scheduled antipsychotic medications. All patients admitted to the units that
were prescribed antipsychotic medications were included in the sample during the pilot project.
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Additional chart audits were conducted on those patients on antipsychotics who had an
abnormal metabolic screening. The determination of an abnormal metabolic screening was not
previously defined at the hospital. Having a high BMI (>25) and two of the following abnormal
values was classified as having an abnormal metabolic screening: high triglyceride levels (>150
mg/dL), low HDL cholesterol (male < 40 mg/dL and female < 50 mg/dL), high blood glucose
(fasting glucose >100 mg/dL or Hemoglobin A1c (HgbA1c) >5.7%), and high blood pressure (two
reading on separate days of systolic blood pressure (SBP) > 130 or diastolic blood pressure (DBP)
> 85) (Hibner et al., 2020; International Diabetes Federation, 2006; Papanastasiou, 2013). Patients
with abnormal screenings were then audited for rates of post-discharge referrals and/or inpatient
consultation for internal medicine or related medical specialists who can follow-up with education
and/or medication for metabolic syndrome. This audit examined the follow-up care and related
patient outcomes that occur when providers do collect the information. Rates were calculated by
dividing the number of patients on antipsychotics with abnormal metabolic screening with referrals
or consults by the number of patients on antipsychotics with abnormal metabolic screening.
The two units were at different locations within the same healthcare system, Unit A with
12 nurses (8.6 FTE, all hospital employees) and Unit B with 13 nurses (9.6 FTE, of which 3.0 FTE
were agency nurses) at the time of implementation. The nurse-driven protocol templates and
approval processes were examined on both units. The information gathered on the units along with
pertinent published literature, including Barto (2019), were used to write the nurse-driven protocol
and the policy around it. The nurse-driven protocol provided a specific if/then procedure for
nursing to follow and included a decision tree graphic. It gave a registered nurse the ability to
collect all four elements of a metabolic screening procedure on a patient taking antipsychotic
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medication without a licensed independent practitioner (LIP) order and provide follow-up care for
those with abnormal metabolic screenings.
The policy was then given to internal stakeholders for feedback and input. Internal
stakeholders included frontline nurses, physicians, chief nursing officer, nurse managers, nursing
directors, medical directors, service chiefs, director of quality and risk, and nursing informatics.
Feedback was given in person during a meeting as well as electronically via email. Following this
internal review and revision, the updated policy was given to an expert panel for validation of
content. The ten steps for using an expert panel from Lazenby et al. (2014)’s article were followed.
The panel was made up of 24 national experts who published research on nurse-driven protocols
(n=10), metabolic screening related to antipsychotics (n=9), and empowerment (n=5). The expert
panel review form (see Appendix E) and formal invitation to participate was simultaneously sent
to the 24 experts via their email addresses associated with their publications. The panel was asked
to rate items on a scale of 1 (not at all) to 4 (very) for relevance and feasibility. Ratings of 3 or 4
were affirmative and the item was considered relevant or feasible. An Item Content Validity Index
(I-CVI) was calculated for each part of the protocol with the numerator being the sum of experts
rating in agreement (ratings of 3 or 4) and the denominator being the number of experts rating the
item. The goal was a I-CVI of 0.78 or above (Polit et al., 2007).
The final policy and decision tree implemented on both units is included in Appendix F.

Aim 2: To implement and evaluate the nurse-driven protocol for metabolic screening
Once the nurse-driven protocol was finalized, the project focused on implementation. First,
the nursing staff on the psychiatric units was educated on the new policy. The focus of the
education was on why it is important, what the steps are, how it will be monitored, and how to
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discuss the topic with patients. Staff were educated via emails and during staff meetings. Emails
included information as well as the policy and decision tree. Role playing for how to communicate
with patients was used during the staff meetings as well as how to proceed through different paths
of the decision tree.
After all appropriate staff had been educated on the new policy, the policy went into effect
in December 2021. For 7 weeks after implementation, biweekly meetings with the managers of
the two units to discuss compliance with the protocol were held. Each unit and their weekly
metabolic screening compliance of patients discharged in the last two weeks were presented and
examined for fidelity to the procedure and the protocol. Five weeks after implementation, there
had been no use of the protocol by nursing staff, so managers and the investigator provided
reminders and re-education of the protocol before the start of the sixth week after implementation.
Even after further education and reminders, the protocol had not been used by nursing staff. The
scope of the protocol was then expanded at the start of week seven after initial implementation to
include nursing leaders, including but not limited to nurse managers, nursing directors and nurses
in the quality department. For the final weeks of the project, meetings and communication with
nurse managers increased to two to three times in a week.
Eleven weeks after the initial implementation of the policy, end of February 2022, the pilot
project was concluded and data via chart audits was collected on CMS compliance for metabolic
screening and follow-up care for those with abnormal screening results via post-discharge referral
or inpatient consultation as described in Aim 1.
The pre- and post-intervention metabolic screening compliance rates and initiation of
follow-up care rates were compared statistically. Descriptive and bivariate analyses were used by
a statistician to determine statistical significance via a chi-square test. Post-intervention audits also
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collected data on who ordered the labs for the metabolic screening (LIP vs. RN) and were
examined via descriptive analysis. The metabolic screening compliance rates were attempted to be
examined using single interrupted time series at weekly intervals; however, a statistician
determined that an interrupted time series analysis was not feasible due to the small sample size
and lack of power.
During pre- and post- intervention audits, non-identifying demographics were also
collected on the patients. It included the age, gender and race of the patient, the antipsychotic
medication, the class of antipsychotic (1st vs 2nd generation), and whether the antipsychotic is
considered high, moderate, or low risk for metabolic syndrome (classifications derived from
Pillinger et al. (2020) and Hasnain et al. (2010)). Table of medication with type and associated risk
for metabolic screening is in Appendix G. Ethnicity was not collected in patient demographics due
to its lack of availability in the electronic medical record. Patient demographics were examined
descriptively, and pre- and post-intervention demographics were compared statistically: a chisquare test for nominal data and one-way ANOVA analysis for continuous data.
Improvement compliance rates of the pilot programs were also compared to the health
system’s overall rate during that time and the average rate for the state published at the time. The
health system’s rates and state rates were retrieved from the CMS Hospital Compare Website.
Confidential and anonymous surveys were given to the nursing staff on the units. A preand post-survey on empowerment was incorporated to gather data on nursing staff’s perception.
Spreitzer (1995) Psychological Empowerment scale (PES) was used to assess nursing
empowerment before and after implementation of the nurse-driven protocol. PES is a 12‐item tool
(3 items per dimension), using a 7‐point Likert scale (Spreitzer et al., 2007). The four dimensions
are meaning, competence, self‐determination, and impact. The scale ranges from 1 (Very Strongly

19

Disagree) to 7 (Very Strongly Agree). The results of the survey were examined for statistical
significance via descriptive, bivariate analysis. The total score and the scores from each dimension
were compared pre- and post-intervention with mean rates via independent samples t-test. The tool
has been determined to have convergent and discriminant validity with a Cronbach alpha reliability
ranging between 0.85 and 0.91 for total psychological empowerment (Laschinger et al., 2004).
The PES tool can be found in Appendix H.
In addition, surveys were also given to nurses on both units to collect data on nursing
perception of the protocol. The post-intervention survey contained both yes-no and open-ended
questions (see Appendix I). Yes-no questions had percentage calculated and analyzed descriptively
for trends and open-ended questions were coded and examined for themes. Both surveys also asked
for non-identifying, nominal demographic information: age range, year range of experience as a
registered nurse, gender, primary worked shift, education, and completion of psychiatric nursing
certification (see Appendix I). Staff demographics were examined descriptively. All analyses were
performed using SPSS Version 28 (Armonk, NY: IBM Corp.) and statistical significance was
assumed at an alpha value of 0.05.

Aim 3: To make recommendations for sustainability and scaling of the nurse-driven protocol for
metabolic screening at the corporate systems level
Scaling
The compliance rates, survey results, and implementation process were presented
via PowerPoint presentation during the health system’s quality improvement
meeting. The meeting invited the president of the corporate system, the chief
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nursing officer, the chief medical officer, the chief medical informatics officer and
director of quality.

Sustainability
Metabolic screening compliance rates continue to be assessed on a monthly basis
per hospital protocol by the quality department. Missed screenings will be
examined by the quality department and the nurse manager and medical director
will follow-up with appropriate staff when hospital policy is not followed. Nurse
managers will be responsible for education of new staff members on the policy.
The project, its process, and its results will be disseminated via poster presentation
at American Psychiatric Nurses Association (APNA)’s annual conference and
published.

Implications
The project should first and foremost improve metabolic screening compliance rates, which
are a publicly reported quality indicator for inpatient behavioral health units. Furthermore, by
increasing metabolic screening, this model could help prevent and reduce metabolic syndrome.
Metabolic screening can also assist with medication compliance, which impacts risk of hospital
readmission (Mutsatsa et al., 2003; Verdoux et al., 2000). In addition, bringing nurse-driven
protocols to behavioral health units can also increase nurse empowerment. Nurses who feel
empowered report higher levels of quality in their patient care (Laschinger et al., 2001; Laschinger,
2008). Nursing empowerment has been shown to increase staff retention, job satisfaction,
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organizational trust, unit effectiveness, and positive coworker relationships (Brady & Cummings,
2010; Read & Laschinger, 2015; Regan et al., 2016; Sarmiento et al., 2004).
Furthermore, implementation of this project can also have a financial benefit for
organizations. The direct benefits are related to improving efficiency and productivity, since the
average salary of nurses is lower than LIPs. In addition, the internal resource of the LIPs can be
utilized elsewhere with the additional time. The indirect benefits arise from reducing nursing staff
turnover. Behavioral health has one of the highest turnovers in nursing by specialty at an annual
rate of 20.6% (NSI Nursing Solution Report, 2020). If the increase in empowerment reduces staff
turnover as projected, $44,375 would be saved for every nurse that is retained (NSI Nursing
Solution Report, 2020). A proposed return on investment (ROI) is found in Appendix J.

Human Subjects

This project was deemed to be clinical quality improvement by the Yale University IRB
guidelines and by the health system’s IRB. There will be no greater risk to the patients or staff
than what is involved with typical care and all patient and staff information was de-identified.

Project Timeline
The project started after the proposal defense on July 15, 2021 and concluded at the end of
spring semester of 2022. A Gantt chart is found in Appendix K.

Leadership Immersion
This project took place at two different locations within the same health system with the
respective hospital leadership to implement and sustain a nurse-driven protocol to improve
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metabolic screening for patients on antipsychotics. Meetings were held with external experts to
develop leadership skills or discuss challenges during the implementation of this project. In
addition, presentations and a publication were developed related to this project to assure
dissemination to other mental healthcare providers. The project addressed multiple American
Association of Colleges of Nursing (AACN)’s DNP Essentials, specifically Essentials II
(Organizational and Systems Leadership for Quality Improvement and Systems Thinking) and VII
(Clinical Prevention and Population Health for Improving the Nation’s Health).
The project addressed DNP Essential II by working with leadership at two different
locations to help improve quality care and promote excellence in practice. Meetings with hospital
leadership of nursing and quality on a regular basis to discuss progress and possible adjustment to
protocols were involved. Skills involved working within the organization to become proficient in
quality improvement strategies and in creating and sustaining changes. This project aimed to
improve reported quality measurements for psychiatric inpatients. Project results were reviewed
with hospital leadership to determine how to scale the project to be incorporated in the healthcare
system.
The project addressed the DNP Essential VII by working on clinical prevention of
metabolic syndrome of a vulnerable population, those with mental health disorders. By increasing
screening for metabolic syndrome and increasing referrals, this project aimed to prevent the
syndrome and the increased risks associated with it. Patients with metabolic syndrome suffer from
high blood pressure at increased rates which places them at twice the risk for death, three times
the risk of heart attack or stroke and five times the risk of developing type 2 diabetes when
compared with the general population (International Diabetes Federation, 2007). Increased
screening can also lead to interventions focused on unhealthy lifestyle behaviors that can also
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contribute to the syndrome. The project developed and implemented health policy at the
institutional level with the plan to expand to further levels.
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Chapter Four
Results
The project successfully implemented a nurse-driven protocol for metabolic screening on
two psychiatric units. The results from each aim are described in further detail in this chapter. Data
in table format related to the expert panel, metabolic screening rates, and nursing survey on
empowerment and perception are found in Appendix L.

Aim 1: To develop a model nurse-driven protocol for metabolic screening and education of
inpatients on antipsychotic medication
The initial draft of the protocol was developed from the literature review found in Chapter
2. The protocol contained multiple steps of a decision pathway, starting with identifying if a patient
is ordered an antipsychotic medication and if a metabolic screening was completed in the last
twelve months. If a patient on an antipsychotic is missing a component of the metabolic screening,
the nurse would complete it, including ordering missing lab work without a LIP. Lastly, the nurse
would initiate follow-up care for an abnormal screening, either via an internal consult or postdischarge referral.
Feedback on the protocol was then gathered from internal stakeholders at both locations.
Most updates to the protocol came from in-person meetings with the nursing director and medical
director at unit A, specifically how the nurse would enter the order for labs, what steps the nurse
should take if there is an abnormal screening, what values made a screening abnormal, and
including designees (like a technician) for tasks like vital signs, height, and weight. Other internal
stakeholders were asked for feedback after these updates. While their responses were all supportive
of the protocol, none provided any feedback that led to update of the protocol. The medical
director, nurse manager, nurse director at unit B and the nurse manager and medical service chief
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at unit A provided feedback via email. The other internal stakeholders also included system-wide
leadership: the chief nursing officer (in-person), director of quality (via video conferencing),
director of social work (in-person) and lead nursing informaticist (email).

Expert Panel
After the internal stakeholder review and updates, the protocol was reviewed by the expert
panel. Of the 24 experts to whom an expert panel review form (Appendix E) was sent, nine (38%)
completed the content validation questionnaire: three experts on nurse-driven protocols, five on
metabolic screening, and one on empowerment. More participating experts identified with the role
of a nurse (56%) with the rest identifying with the role of physician (44%). Most participating
experts were based in North America (78%). Demographics of the expert panel members that were
invited and participated are in Table 1. Names, credentials, and affiliations of expert panel
members that participated and agreed to be acknowledged are found in Table 2.
All items had a I-CVI of 0.78 or above, except feasibility for the item involving follow-up
steps for an abnormal screening (V.7, I-CVI=0.75). Three panelists commented that this item had
two possible options (consult or post-discharge appointment) but did not give direction on when
each would be appropriate to perform. Edits were made to the protocol and decision-tree to specify
when each is appropriate: If an abnormal metabolic screening is found, nursing will place an order
for an internal medicine consult and discuss with the treatment team. If the patient has a planned
discharge within 2 days, the nurse will also request a referral for a post-discharge appointment
with a primary care provider for follow-up.
All items had I-CVI of 1.0 for relevance, except the item involving the determination if a
screening is abnormal by a nurse (V.6, I-CVI=0.89). One expert commented that having the
protocol instruct nurses to review lab results are irrelevant as it is something nurses should be
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performing regularly. Results of the expert panel on the relevance and feasibility of the protocol
are found in Table 3.
Panelists were also asked for their expert opinion on assumptions that this project makes
based on metabolic screening, nurse-driven protocols, and empowerment. All questions were
answered by six experts, while the remaining three only answered some of the questions (8 to 15
questions). Regarding metabolic screening, all experts agreed on the components and timing of
metabolic screenings used in this project; all but one expert agreed an LIP was not needed for a
metabolic screening and that a follow-up with an internist would benefit a patient with an abnormal
screening. Secondly, regarding the nurse-driven protocol, all experts agreed that nurses could
understand and implement the protocol, that nurses can examine the medical record for
components, collect and evaluate patient’s BMI and blood pressure, and that the protocol does not
increase any risk of harm to patients. One expert disagreed that nurses would be likely to follow
the protocol and two experts (both nurses) disagreed that nurses can draw the missing labs without
an LIP, even with the protocol proposed in place. Lastly, regarding empowerment, all experts
agreed that the protocol would increase nursing autonomy and empowerment, that nurses would
be provided additional responsibility related to metabolic screening, and that nurses and other staff
would be satisfied with the protocol. One expert disagreed that patients would be satisfied with the
protocol. The results of the optional questions are found in Table 4.

Aim 2: To implement and evaluate the nurse-driven protocol for metabolic screening
The implementation of the protocol started with education of the staff on the two units.
Email communication was sent out to all nurses (n=25) on both units with the purpose of the
project, the protocol, and the date and time the investigator would be at each unit’s staff meeting
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by the unit’s respective manager. The staff meeting with unit A had eight of 12 invited nurses
(66.7%) in attendance. The staff meeting with unit B had six of 13 invited nurses (46%) in
attendance. In each meeting, two nurses used the protocol and decision tree on two current patients
on the unit and then role-played education to the investigator and unit manager as if they were
patients. Education was also reinforced on both units, five weeks after implementation. Emails
were sent to all nurses (n=25) on both units with reminders about the project and its importance
by the unit’s respective manager. The investigator also went over the protocol and answered any
questions with staff (n=18, 72%) with impromptu, in-person training on both units.

Metabolic Screening Compliance Rates
Chart audits were completed on all patients discharged (n=341) over the 20 weeks of the
pre- and post-intervention periods. Of those patients, 85% (n=290) were discharged on
antipsychotic medication and analyzed. The pre-intervention chart audits (weeks 1-10) included
150 patients discharged on antipsychotic medication and the post-intervention chart audits (weeks
11-20) included 140 patients discharged on antipsychotic medication. The post-intervention group
was divided into two time periods, post-intervention Time 1 (T1) (n= 95, 7 weeks, week 11-17)
and post-intervention Time 2 (T2) (n=45, 3 weeks, week 18-20), corresponding to the initial
protocol implementation and the change in protocol to include nurse manager involvement.
Statistical analysis of the demographics of the patients discharged on antipsychotics showed no
significant difference in age, gender, race, generation of antipsychotic or risk level. Demographics
of the patients discharged on antipsychotics are included in Table 5.
Out of 150 patients in the pre-intervention group, 100 patients discharged on antipsychotics
had a complete metabolic screening resulting in a 66.7% compliance rate. Out of the 140 patients
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in the post-intervention group, 106 patients discharged on antipsychotics had a complete metabolic
screening resulting in a 75.7% compliance rate. When comparing compliance rates of the preintervention group (66.7%) and post-intervention T1 (69.5%), the metabolic screening compliance
rates of post-intervention T2 (88.9%) were significantly higher (p < .05) as were rates of obtaining
lipid panels which increase from 74.7% and 72.6% to 93.3%. Other indices of screening did not
change significantly. There was an increase of obtaining glucose levels from 90.6% to 97.7% (see
Table 6).
The patient outcome measure for the protocol was referral for a consult or follow-up care
prior to discharge if an abnormal metabolic screening was present. Of 206 patients discharged with
completed metabolic screenings from pre- to post-intervention, 90 screenings were abnormal
(43.7%) and of those 90 abnormal screenings, only 39 patients (43.3%) received some form of
follow-up care, of whom medical consultation was obtained in 87% while in-hospital and referral
at discharge was provided for 44%. The patient outcomes for each group are found in Table 7.
There were no significant differences in outcomes between groups.
The nurse-driven protocol was used 40 times during the post-intervention weeks: 11
HbA1C were ordered and resulted, 9 lipid panels were ordered and resulted, and an additional 20
orders were placed but the patient refused phlebotomy. Overall, the protocol helped complete an
additional 14 patients’ metabolic screening that otherwise would not have been completed.

Nursing Survey of Empowerment and Perception
The pre- and post-surveys including Spreitzer’s Psychological Empowerment scale (PES)
were distributed via paper form by their respective unit manager to all employed nurses on both
units (pre-survey n=25 and post-survey n=22). Pre-surveys were returned before the start of
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project implementation by 13 nurses (52%): six (50%) from unit A and seven (54%) from unit B.
Post-surveys were returned by 8 nurses (36%) during weeks 19 and 20: all eight were from unit
A. Multiple attempts were made via emails and in-person to nurses on unit B requests by manager
and the investigator to get survey responses but no nurses filled out the post-survey.
On each survey, nurses were asked for demographics: employer, role, unit, age, years of
experience, gender, nursing education, and certification. The majority of participating nurses
identified as female, registered nurses that were hospital employees with a bachelor’s degree.
There was no significant difference in characteristics between those that participated in the preand post-surveys. Demographics of surveyed staff are located in Table 8.
The average PES score (ranging from 1 to 7) from surveyed nurses were 5.72 (SD=0.75)
pre-intervention and 5.60 (SD=0.64) post-intervention. These scores fall between the 55th and 60th
percentile. The PES contains four dimensions: meaning, competence, self‐determination, and
impact. The meaning subscore (6.38 for both surveys) was the highest dimension for both survey
and the impact subscore (4.62 pre-survey and 4.86 post-survey) was the lowest dimension. The
mean subscore of the four dimensions and the total score for empowerment are found in Table 9
for pre- and post-survey groups. The t-test compared the means of the subscore and total score
between the pre-survey group and the post-survey group and found no significant difference in the
scores: p-values are located in Table 9.
Post-survey also contained questions on nurses’ perception on the nurse-driven protocol.
The results of the yes-no questions suggest an overall negative perception of the protocol by the
participating nurses (see Table 10). The highest affirmative question was that metabolic screening
is the responsibility of the physician (75%), although 63% agreed that nurses also had
responsibility related to metabolic screening. Most of the questions received disagreeing
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responses. Only 29% of the post-surveyed nurses agreed that the protocol was helpful and only
38% agreed that the protocol was empowering, while 57% found the protocol easy to use and 43%
liked using the protocol.
The first open-ended question examining nurses’ feeling towards the protocol had themes
of no feelings due to not using (n=4) and feelings of wanting more instructions on how to use the
protocol (n=2). One response stated that the protocol was confusing and another response stated
that the protocol was liked but not used. The second open-ended question, which examined reasons
that prevented nurses from using the protocol, found themes of not using due to acuity on the unit
and lack of time (n=2) and due to lack of opportunity to use (n=2). One response identified that
there was no opportunity to use the protocol also shared that the screening is already done by the
physician.

Aim 3: To make recommendations for sustainability and scaling of the nurse-driven protocol for
metabolic screening at the corporate systems level
The findings of this project were presented at the health system’s quality improvement
meeting for scaling consideration. The chief nursing officer, the chief medical officer, the chief
medical informatics officer and director of quality as well as varying nursing and physician leaders
were in attendance. There, next steps and barriers to scaling the pilot program to other units were
discussed. Multiple nursing leaders had concerns with placing more responsibilities on unit
managers during a nursing shortage and pandemic. However, there was discussion on expanding
the use of a nurse-driven protocol for smoking cessation medication along with ideas to pilot that
protocol on two other units. The discussion of scaling ended with plans to involve other
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stakeholders of other behavioral units within the system, including but not limited to the nursing,
medical, quality, and educational leadership.
As of the date of submission of this paper, an abstract to present a poster at the American
Psychiatric Nurses Association (APNA)’s annual conference has been accepted. Furthermore, a
manuscript on this project, its implementation, and results is being drafted for publication in a
psychiatric/nursing journal.
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Chapter Five
Discussion
Key Findings
A protocol and policy were developed to guide nurses on completing a metabolic screening
and steps to take for an abnormal screening. Staff were involved in the development of the protocol
with feedback via staff meetings and email; however, the protocol was the agreed upon solution
to lack of metabolic screening before frontline staff were consulted. Once the protocol and policy
were developed and updated by hospital staff and leadership, it was validated by an expert panel
which had an overall positive perception of the protocol, although some questioned the feasibility
at certain steps, particularly how the nurse would handle abnormal screenings. Over the ten weeks
after implementation of the protocol and policy, no frontline nursing staff used the protocol. There
was no change in nursing empowerment and an overall negative perception of the protocol existed.
The protocol might have garnered more use if staff had more involvement in its creation and
education from the start. A shared governance model of presenting the problem and working with
staff to create a solution could have created more engagement in the staff.
The survey results on nursing perception support Beck & Johnson (2008)’s finding that
nurses thought nurse-driven protocols were not easy and that nurses lacked confidence in their use.
In addition, the empowerment survey further supports Beck & Johnson (2008)’s finding that nursedriven protocols had no effect on autonomy. The results differ from Olson-Sitki et al. (2015)’s
findings since empowerment did not increase for nurses that did not use the protocol. While
multiple studies show the benefit to patient outcomes with the nurse-driven protocols, few study
the perception of the nurse on using these protocols. Nurses need to be part of the development of
nurse-driven protocols and how it may affect their work and scope of practice.
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While PES scores did not significantly change after the protocol implementation, the PES
results (5.72 and 5.60) did show lower empowerment, compared to international nurses from
Fragkos et al.'s (2020) meta-analysis of nine articles using the PES tool (mean score 6.42).
However, compared to the PES mean score (4.97) of 222 US nurses surveyed using PES in Sparks
(2011), the PES results (5.72 and 5.60) show higher empowerment. The subscores in meaning
(6.38 and 6.38 vs. 5.70), self-determination (5.89 and 5.19 vs. 4.89), and impact (4.62 and 4.86 vs.
3.51) were also higher in nurses surveyed for this project, compared to nurses surveyed in Sparks
(2011). Further studies examining the PES of nurses in varying specialties would be useful in
determining if the project’s PES scores were higher due to the fact that all surveyed nurses were
in the psychiatric specialty.
After the protocol was adjusted at the start of week 18 (post-intervention T2), nursing
leaders did use the protocol and there was a statistically significant increase in metabolic screening.
The increase suggests that the socialization of a nurse-driven protocol in this psychiatric setting
may start with nurse managers and other nurse leaders involved in the quality of patient care.
Studies have already shown that metabolic screening compliance increases with an engaged
leadership around the topic (Melamed et al., 2021; Melamed et al., 2019). Nurse managers could
lead by example and use the protocol but could also follow-up with frontline staff (nurses and
physicians) on reasons why the protocol was not used and hold staff accountable. On the other
hand, a nurse navigator in the quality department could also be responsible for auditing metabolic
screenings, along with other quality metrics, and place orders in real-time and later following up
on the missing indices. Furthermore, this engagement could also help with physician participation
in metabolic screening and show its importance as a priority for quality psychiatric care, since
physicians report metabolic screening to be a low priority (Chee et al., 2017). With the consensus
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of who is responsible for metabolic screening shifting to the psychiatric providers (Laugharne et
al., 2016; Mangurian et al., 2019), physicians also need to be a part of intervention to increase
metabolic screening.
The screening rates pre-intervention were similar to the systematic review that found on
average, one-third of patients were not screened (Melamed et al., 2019). However, postintervention T2 lowered the rate such that only one out of every ten patients were not screened.
Compared to Hibner et al. (2020) pharmacist- and nurse-driven protocol (42.5% and 31.3%) and
Osborn et al.’s (2010) nurse-led intervention (66.7% and 66.7%), post-intervention T2 completion
rates of glucose levels (90%) and lipid panels (93%) were higher. The rates for screening for the
two units post-intervention were also higher than publicly reported rates for the health system as a
whole as well as the state and national averages. As of the end of March 2022, the health system
had a 29% compliance rating for metabolic screening on the CMS Hospital Compare Website. The
state average was 38% and the national average was 77%.
While metabolic screening did increase after the protocol was adjusted, the follow-up care
for abnormal screenings did not change. While screening is the first step, in order to benefit patients
and improve outcomes, intervention needs to take place for patients with abnormal metabolic
screenings. The standard of practice for intervention still needs to be agreed upon by the medical
and psychiatric communities. With the current research showing an emerging consensus that the
screening itself is the responsibility of the psychiatrist, the responsibility of the follow-up
interventions of an abnormal screening requires further research.

Limitations
Two major limitations around use of the protocol relate to the unit staffing and COVID-19
pandemic. Due to the nursing shortage that was worsened by the pandemic, both units ran with
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fewer nurses: most shifts during the study timeframe had two fewer nurses than the budget called
for. In addition, the global COVID-19 pandemic created frequent policy changes that were
required to keep staff and patients safe. With these two limitations in mind, the nurses working on
the floor had more patient responsibilities than usual and had new policies and extra care to provide
due to the pandemic. The staff nurses’ main priority was safety so they may not have had adequate
time during their shift to focus on improving quality and their own autonomy.
In addition, due to the nature of quality improvement designs, the project results are not
generalizable and do not show definitive causation. The project took place on two clinical units
over a limited time period. Besides the protocol implementation, there could have been
confounding factors impacting the results, including but not limited to increased discussion on the
units around metabolic screening due to the project and focus on increasing all quality metrics by
the overall health system. The health system has also been discussing ways to increase the publicly
reported quality metrics, including metabolic screening. With more discussion of metabolic
screening on the units from the project and the health system, LIPs may have increased their
screening. There was no randomization of the protocol implementation and no group to control for
confounding factors; however, future studies could use a randomized nested design.
The project could also lack internal validity, including regression to the mean, response
bias, selection bias, and attrition bias. The results show an improvement in screening over a short
period; the results could regress back to the mean if captured over a longer period of time.
Furthermore, response bias around the empowerment survey could exist. Since the survey were
self-reported, participants could have been giving answers that they thought the surveyor wanted,
like higher scores for empowerment. The survey could have had selection bias with nurses feeling
more empowered answering the survey and attrition bias with nurses feeling less empowered not
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responding to the second survey. The staff were working on a busy unit during a pandemic; the
potential burn-out could have also played a role in the lack of survey responses.

Future Implications
While the project aimed to increase the autonomy of nurses, it also further diffused the
responsibility of metabolic screening. On units where the protocol is implemented, both nurses
and physicians would be responsible to ensure the screening is complete and one could assume
that the other has or will complete it. If the protocol is implemented, team accountability needs to
be utilized. Furthermore, more research on perception of nurse-driven protocols is needed,
including but not limited to the perception of patients, physicians, and nurses. In addition, ways to
increase nursing empowerment and make nurses more autonomous need to be further explored.
Technology could also be leveraged to improve metabolic screening and use of nursedriven protocols. While some electronic medical records (EMR) can automatically remind LIPs to
enter orders for metabolic screening when ordering antipsychotic medications, the EMR could also
remind nurses to complete the metabolic screening indices when they are administering the
antipsychotic medication. In addition, the use of automatic reports to leadership on patients on
antipsychotics without screenings could help target missed opportunities. A standardized process
on when the screening is expected to be completed and regular audits on completion would also
be needed.
Another issue that arose from the project is patients refusing screening, especially around
indices that required phlebotomy. While nurses using the protocol and LIP may have entered order
for lipid panels and glucose tests, if the patient refused, the screening could not be completed.
Future work needs to be done on engaging patients in the screening and helping them understand
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its importance. There also needs to be continued follow-up after refusal. Patients may be too
psychotic during the first few days of admission to understand why the screening is needed,
however that is usually when providers attempt to screen the patients. With continued follow-up,
staff could attempt to complete the screening closer to discharge when the psychotic symptoms
have improved or resolved.
There is limited use of nurse-driven protocols in the mental health sector, even though there
have been many uses in the medical sector. Future work is needed on socializing the use of nursedriven protocols on psychiatric inpatient units focusing on potential benefits to patient outcomes.
Nurse-driven protocols could also be used for smoking cessation medications, which is another
quality metric, as well as for safety sitters, which is a major financial metric for most hospitals. In
addition, nurse-driven protocols could also be used for follow-up care for abnormal metabolic
screening. The protocol could allow nurses to not only make referrals to internal medicine but also
follow an algorithm start treatment of the metabolic syndrome, like a statin or metformin.

Conclusion
Metabolic syndrome is a major health risk for people taking antipsychotic medication;
however, screening for metabolic syndrome in this population is suboptimal. This project aimed
to improve metabolic screening for inpatients on antipsychotics by implementing a nurse-driven
protocol. The nurse-driven protocol allowed nurses to collect all four indices of a metabolic
screening. Implementation showed that frontline staff nurses did not use the protocol; however,
nursing leaders did use the protocol, which resulted in a significant increase in metabolic
screenings. There was no change in nursing perception of empowerment or follow-up care for
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patients with an abnormal metabolic screening. More work is needed for acceptance of nursedriven protocols on mental health units.
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Appendix A
Adapted PRISMA Flow Diagram for Review of Literature
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and MetaAnalyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed

Records identified through
database searching
(n = 334)

Additional records identified
through other sources
(n = 0)

Records after duplicates removed
(n = 138)
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(n = 138)

Records excluded after
full-text assessed for
relevance
(n = 39)

Records excluded after
abstracts assessed for
relevance
(n = 79)

Full-text articles assessed
for relevance
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Studies included in ROL
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Studies included in current
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Appendix B
Evidence Table

Evidence Table is not included in this submission. Please contact primary author with any questions or requests.
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Appendix C
Rosswurm and Larrabee’s revised Model for Evidence-Based Practice Change
Research
literature for
best evidence
for improving
rates of
metabolic
screening as
well as use of
nurse-driven
protocols

Evaluate
current
practice for
metabolic
screening and
assess current
CMS
compliance
rates compared
to standards

Present pilot
study findings to
the other
inpatient mental
health units in the
corporations as
well in publication
and post
presentations

Critically analyze
searched evidence
and weigh
strength and
assess feasibility
with other
stakeholders

Implement nursedriven protocol on
the pilot units,
monitor outcomes
by observing CMS
compliance rates
of metabolic
screening and
referrals

Develop policy
and nurse-driven
protocol for
metabolic
screening and
develop roll-out
and education
plan

Larrabee, J. H. [2009]. Nurse to nurse: Practice. New York, NY: McGraw-Hill.
Melnyk, B. M., & Fineout-Overholt, E. (2015). Evidence-based Practice in Nursing & Healthcare:
A Guide to Best Practice. Wolters Kluwer Health.
*Permission granted for use and reprinting of figure by McGraw Hill LLC and Wolters Kluwer Health, Inc.
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Appendix D
SWOT Analysis Table
Strengths

Weaknesses

•

Focused on mental health resources

•

High RN turnover

•

Strong brand recognition

•

Limited nurse recognition

•

Emphasis on research

•

No nurse-driven protocols

•

Expanding services

•

Limited nursing research

•

High staff-to-patient ratio
Opportunities

•

Threats

Collaboration with acute care
hospitals

•

•

Competitive job market

•

Low Centers for Medicare &
Medicaid Services’ psychiatric quality

Nationally ranked and recognized

measures
•

State safety net hospital for mental
health disorders
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Appendix E
Content Validation Questionnaire for Expert Panel
Directions: This project aims to increase metabolic screening for patients on antipsychotic medication in the inpatient setting. First,
please review the attached metabolic screening protocol and flow chart. Then, read each component of the protocol below and rate
each component on relevance to accomplishing the aims and goals and its feasibility. Place a number (1-4) in each box and please
make any comments or suggestions next to each item. Following the rating form, there are optional agree/disagree questions to help
gain more information about the three topics surrounding this protocol. At the end, there are questions regarding your role in
healthcare and if you are willing to have your name acknowledged in posters and publications. Thank you for your time.

Protocol
*EMR = electronic medical record
Item

Is the item relevant?

Is the item feasible?

4- Very relevant
3-Moderately
relevant
2- Somewhat
relevant
1- Not at all relevant

4- Very feasible
3-Moderately
feasible
2- Somewhat
feasible
1- Not at all feasible

IV. Policy
1.If a patient is on a standing dose or longacting injection of an antipsychotic
medication, a metabolic screening must be
performed at least once every 12 months,
including baseline results prior to the
initiation of an anti-psychotic.
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Please make any comments or suggestions about
the item.

V. Procedure
1. If a patient is ordered a standing dose of
antipsychotic medication or a one-time dose
of an antipsychotic long acting injectable, the
nurse should check the medical record to see
if all elements of a metabolic screening were
performed in the last year (12 months).
V. Procedure
2. On admission and the day after admission,
the nurse (or designee delegated by a nurse)
will take the patient’s blood pressure and
enter it into the EMR*.
V. Procedure
3. On admission, the nurse (or designee
delegated by a nurse) will measure the
patient’s height and weight, enter the values
into the EMR*, and the EMR* will
automatically calculate the patient’s BMI
V. Procedure
4. If there is no record of the patient having a
Lipid Panel or Hemoglobin A1c in the last 12
months, the nurse will order the needed
lab(s) as a compliance-initiated order under
the attending physician in the EMR* as an
AM lab for the next day (or if appropriate
timing, the nurse can draw after placing
order, if the nurse is competent in
phlebotomy). If the order was previously
placed but not completed for any reason, the
nurse will re-order the lab(s) as above.
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a. Records can be from another
hospital but must be within the last 12
months and must be placed in the
chart.
V. Procedure
5. Before any element is obtained, the nurse
should instruct the patient on the process,
along with the purpose and importance of the
metabolic screening. Nurse should also
educate the patient to fast before lipid panel
lab draws in order to obtain more accurate
results.
V. Procedure
6. The nurse should review and acknowledge
results of the four components of the
metabolic screening as they are entered into
the EMR*. Once all results are present, a
nurse can determine if the screening is
abnormal. Criteria for an abnormal metabolic
screening are attached below.
V. Procedure
7. If an abnormal metabolic screening is
found, nursing will place an order for an
internal medicine consult and/or the nurse
will inform the treatment team to make a
post-discharge appointment with a primary
care provider for follow-up.
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Criteria for Abnormal Metabolic Screening:
see p. 3 of protocol

Flow Chart for Metabolic Screening
Protocol: see p. 4 of protocol

Is anything missing from the policy or procedure in this protocol?

If desired, please offer any comments or suggestion on other parts of the protocol
Item

Please make any comments or suggestions about the item.

I. Scope
This policy applies to nurses on inpatient
psychiatric/mental health units
II. Purpose
• To ensure that all patients on standing dose or longacting injections of an antipsychotic medication are
being assessed for metabolic disorders
• To reduce the risk of preventable adverse events and
improve the physical health status of the patients on
antipsychotic medication, given their association with
increased metabolic risks
• To provide guidelines by which the registered nurse
may order blood work (Lipid Panel and Hemoglobin
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A1c) for patients who are on standing antipsychotics or
long-acting injections
III. Definitions
1. Metabolic Screening: A systematic approach to
identify metabolic risk factors (abdominal obesity, high
blood sugar, high triglycerides, low high-density
lipoproteins and high blood pressure). For the purposes
of this initiative, the following measurements that are
required by CMS will make the metabolic screening:
BMI, blood pressure, Lipid Panel and Hemoglobin A1c.
2. Body-Mass Index (BMI): The weight-to-height ratio,
calculated by dividing one’s weight in kilograms by the
square of one’s height in meters.
3. Lipid Panel: Blood work that includes total
cholesterol (TC), triglycerides (TG), high density
lipoprotein (HDL), and low-density lipoprotein (LDL-C)
levels
Optional questions: Please check one box under agree or disagree for each of the statements below. Feel free to add any additional
comments related to each statement.

Metabolic Screening
Statement

Agree

Disagree

Metabolic screening should include blood draws,
specifically Lipid Panel and glucose (fasting
and/or Hemoglobin A1c.
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Please make any comments about the statement.

Metabolic screenings should occur at least yearly
(or more frequently) for patients on antipsychotic
medications.
Inpatients with abnormal metabolic screenings
would benefit from having an inpatient internal
medicine consult and/or a post-discharge
appointment with a primary care provider.
An independently licensed practitioner is not
always needed to determine if a metabolic
screening should occur, when a metabolic
screening protocol exists.
Appropriate metabolic screening can help
increase medication compliance of antipsychotics.
Overall comments regarding metabolic screening and this protocol:

Nurse-driven protocol
Statement

Agree

Disagree

Nurses will be able to understand and implement
the protocol.
Nurses will be likely to follow the protocol
regularly.
Nurse can examine patient records for
components of metabolic screening.
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Please make any comments about the statement.

Nurses can draw missing labs without referring to
a physician or other independently licensed
practitioners when a nurse determines it is
appropriate using a metabolic screening protocol.
Nurses can take a patient’s height and weight and
calculate a Body mass index (BMI) without
referring to a physician or other independently
licensed practitioners when a nurse determines it
is appropriate using a metabolic screening
protocol.
Nurses can take a patient’s blood pressure
without referring to a physician or other
independently licensed practitioners when a nurse
determines it is appropriate using a metabolic
screening protocol.
The protocol is safe and does not increase any
risk of harm to the patient.
Overall comments regarding nurse-driven protocols and this protocol:

Nursing Empowerment
Statement

Agree

Disagree

The protocol will increase nursing autonomy
and/or nursing empowerment.
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Please make any comments about the statement.

Nurses will have additional responsibility for
metabolic screening and for achieving the goal
of better patient outcomes.
Nurses will be satisfied with the protocol.

Patients will be satisfied with the protocol.

Other staff (physicians, pharmacists, case
managers, etc) will be satisfied with the protocol.
Overall comments regarding empowerment and this protocol:

1. Which one healthcare role do you best identify with? (If you answer no to question 2, this answer will only
be used in the aggregate)
□ nurse
□ physician
□ pharmacist
□ other: __________________________________
2. Are you willing to be acknowledged in papers and/or presentations as participating in this expert panel?

□YES

□NO

If yes, please provide your name and degrees/credentials as you’d like them to appear:
__________________________________________________________________________________
If yes, please provide any current affiliations:
_________________________________________________________________________________
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Appendix F
Nurse-Driven Protocol

Metabolic Screening Protocol
I.

Scope
This policy applies to nurses on inpatient psychiatric/mental health units

II.

Purpose
•
•
•

III.

To ensure that all patients on standing dose or long-acting injections of an
antipsychotic medication are being assessed for metabolic disorders
To reduce the risk of preventable adverse events and improve the physical health status
of the patients on antipsychotic medication, given their association with increased
metabolic risks
To provide guidelines by which the registered nurse may order blood work (Lipid
Panel and Hemoglobin A1c) for patients who are on standing antipsychotics or longacting injections

Definitions
1. Metabolic Screening: A systematic approach to identify metabolic risk factors (abdominal
obesity, high blood sugar, high triglycerides, low high-density lipoproteins and high blood
pressure). For the purposes of this initiative, the following measurements that are required by
CMS will make the metabolic screening: BMI, blood pressure, Lipid Panel and Hemoglobin A1c.
2. Body-Mass Index (BMI): The weight-to-height ratio, calculated by dividing one’s
weight in kilograms by the square of one’s height in meters.
3. Lipid Panel: Blood work that includes total cholesterol (TC), triglycerides (TG), high density
lipoprotein (HDL), and low-density lipoprotein (LDL-C) levels

IV.

Policy
1. If a patient is on a standing dose or long-acting injection of an antipsychotic medication, a
metabolic screening must be performed at least once every 12 months, including baseline
results prior to the initiation of an anti-psychotic.

V.

Procedure
1. If a patient is ordered a standing dose of antipsychotic medication or a one-time dose of an
antipsychotic long acting injectable, the nurse should check the medical record to see if all
elements of a metabolic screening were performed in the last year (12 months).
2. On admission and the day after admission, the nurse (or designee delegated by a nurse) will
take the patient’s blood pressure and enter it into Sunrise.
3. On admission, the nurse (or designee delegated by a nurse) will measure the patient’s height
and weight, enter the values into Sunrise, and Sunrise will automatically calculate the
patient’s BMI
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4. If there is no record of the patient having a Lipid Panel or Hemoglobin A1c in the last 12
months, the nurse will order the needed lab(s) as a compliance-initiated order under the
attending physician in Sunrise as an AM lab for the next day (or if appropriate timing, the
nurse can draw after placing order, if the nurse is competent in phlebotomy). If the order was
previously placed but not completed for any reason, the nurse will re-order the lab(s) as
above.
a. Records can be from another hospital but must be within the last 12 months and must
be placed in the chart.
5. Before any element is obtained, the nurse should instruct the patient on the process, along
with the purpose and importance of the metabolic screening. Nurse should also educate the
patient to fast before lipid panel lab draws in order to obtain more accurate results.
6. The nurse should review and acknowledge results of the four components of the metabolic
screening as they are entered into Sunrise. Once all results are present, a nurse can determine
if the screening is abnormal. Criteria for an abnormal metabolic screening are attached below.
7. If an abnormal metabolic screening is found, nursing will place an order for an internal
medicine consult and discuss with the treatment team. If the patient has a planned discharge
within 2 days, the nurse will also request a referral for a post-discharge appointment with a
primary care provider for follow-up.
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Criteria for Abnormal Metabolic Screening
To have an abnormal metabolic screening, a patient will have a BMI of 25 or higher and two of
the following:
1.
2.
3.
4.

high triglyceride levels (>150 mg/dL)
low HDL cholesterol (male < 40 mg/dL and female < 50 mg/dL)
hemoglobin A1c (HgbA1c) >5.7%
high blood pressure (two reading on separate days of systolic blood pressure (SBP) > 130
or diastolic blood pressure (DBP) > 85

Developed from the following articles:
Hibner, T. A., Wakefield, A. N., Eaves, S. M., Gonzalvo, J. D., Macik, M. R., & Williams, G. D.
(2020). Metabolic monitoring of second-generation antipsychotics: Evaluation of a
pharmacist- and nurse-driven protocol. J Am Pharm Assoc (2003), 60(5s), S88-s92.
https://doi.org/10.1016/j.japh.2020.04.016
International Diabetes Federation. (2006). The IDF consensus worldwide definition of the
metabolic syndrome. International Diabetes Federation.
https://www.idf.org/component/attachments/attachments.html?id=705&task=download
Papanastasiou, E. (2013). The prevalence and mechanisms of metabolic syndrome in
schizophrenia: a review. Therapeutic advances in psychopharmacology, 3(1), 33-51.
https://doi.org/10.1177/2045125312464385
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START

Flow Chart for Metabolic Screening Protocol

Is the patient
admitted to an
inpatient psych
unit?

YES

Is the patient
on standing
order of
antipsychotics?

NO

YES

NO

END

Does the patient
have records of a
metabolic
screening in the
last 12 months?

YES
END

NO

END
NO

Place an order for an internal
medicine consult and discuss
with the treatment team
YES

Does the patient
have a planned
discharge within 2
days?

Does the patient
have an
abnormal
metabolic
screening?

YES

NO

END65

Complete missing components of
metabolic screening:
• Take blood pressure
• Take height and weight
• Order/draw fasting Lipid Panel
• Order/draw blood glucose
(fasting blood glucose or HgA1c)

Request a referral for a postdischarge appointment with a
primary care provider for follow-up

Appendix G
Medication Table and Risk Levels

Derived from:
Hasnain, M., Fredrickson, S. K., Vieweg, W. V., & Pandurangi, A. K. (2010). Metabolic syndrome associated
with schizophrenia and atypical antipsychotics. Curr Diab Rep, 10(3), 209-216.
https://doi.org/10.1007/s11892-010-0112-8
Pillinger, T., McCutcheon, R. A., Vano, L., Mizuno, Y., Arumuham, A., Hindley, G., Beck, K., Natesan, S.,
Efthimiou, O., Cipriani, A., & Howes, O. D. (2020). Comparative effects of 18 antipsychotics on
metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and
association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry,
7(1), 64-77. https://doi.org/10.1016/s2215-0366(19)30416-x

*Permission granted for use and reprinting of table by Mehrul Hasnain and Springer Nature
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Appendix H
Empowerment Tool
Psychological Empowerment Scale
Listed below are a number of self-orientations that people may have with regard to their
work role. Using the following scale, please indicate the extent to which you agree or
disagree that each one describes your self-orientation.

____ I am confident about my ability to do my job.
____ The work that I do is important to me.
____ I have significant autonomy in determining how I do my job.
____ My impact on what happens in my department is large.
____ My job activities are personally meaningful to me.
____ I have a great deal of control over what happens in my department.
____ I can decide on my own how to go about doing my own work.
____ I have considerable opportunity for independence and freedom in how I do my job.
____ I have mastered the skills necessary for my job.
____ The work I do is meaningful to me.
____ I have significant influence over what happens in my department.
____ I am self-assured about my capabilities to perform my work activities.

Spreitzer, G. M. (1995). Psychological empowerment in the workplace: Dimensions,
measurement, and validation. Academy of management Journal, 38(5), 1442-1465.
*Permission granted for use and reprinting of figure by Gretchen Spreitzer
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Appendix I
Components of Pre- and Post-Survey

Please select the box that best describes you:

□ Agency □ SP employee
□ Registered nurse (RN)
Home Unit:
Age:

□ Licensed Practical Nurse (LPN)

□ Harbor □ 2H □ Float Pool □ Other:___________________

□ 20-30

□30-40 □ 40-50 □ 50-60

□ 60-70

□ 70 or older

□ less than 1 year □ 1-3 years □ 4-6 years
□ 7-15 years □ 15 or more years

Years of Experience:

Gender:

□ Male □ Female □ Nonbinary

Primary worked shift:
Current Education:
.
.

.

□ Day □Evening □Night

□ Associate’s degree in Nursing or diploma in Nursing
□ Bachelor’s degree in Nursing
□ Graduate degree (MSN, DNP, PhD in Nursing)

Do you currently have a psychiatric nursing certification (example, ANCC’s Psychiatric–Mental
Health Nursing board certification [RN-BC])?

□ Yes □ No
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Please Circle Yes or No for the following questions about the nurse-driven
protocol for metabolic screening:
Did you find the protocol easy to use?

YES

NO

Did you find the protocol helpful in providing care to your patients?

YES

NO

Did you like using the protocol?

YES

NO

Did you find using the protocol empowering?

YES

NO

Do you think the responsibilities under the protocol should fall under the nurse?

YES

NO

Do you think the responsibilities under the protocol should fall under the physician? YES

NO

Please answer following questions about the nurse-driven protocol for
metabolic screening:

How do you feel about the protocol?
.
.
.
.
.
.
What prevented you from using the protocol?
.
.
.
.
.
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Appendix J
Proposed Project Return on Investment

Clinical Improvement Financial Tool
Nurse-driven Protocol to Increase Metabolic
Screening: Financial Analysis

Project Cost Components

Initial

Training*

Year 1

Year 2

Year 3

Assumptions and Notes:

30 RN's & 1.5 hours of training
8,071 15 minutes & 900 patients

1,614

$

-

$

-

$

RN performing protocol*

-

$

8,071

$

8,071

$

Manager weekly follow-up*

-

$

700

$

700

$

700

Unit Supplies (gloves, tubes, needles, etc.)^

-

$

2,059

$

2,059

$

2,059

1,614

$

10,830

$

10,830

$

10,830

Staff turnover reduction~

$

44,375

$

44,375

$

44,375 1 out of 6 expect RN's stay

Total Indirect Benefits

$

44,375

$

44,375

$

44,375

Total Project Costs

$

-

Opportunity or Indirect Benefits/Savings
Indirect Benefits

Direct Benefits/Savings

Initial

Year 1

Year 2

Year 3

Efficiency/Productivity
Effective use of internal resources (MD not ordering)*

$
$

22,617
22,617

$
$

22,617
22,617

$
$

22,617 15 minutes & 900 patients
22,617

-

$

66,992

$

66,992

$

66,992

-

$

22,617

$

22,617

$

Total Direct Benefits
Total Benefits

$

Total Direct Benefits
(Less) Total Project Costs
Improvement due to Direct Benefits

$

(1,614)
$

(10,830)

(10,830)

(1,614) $

11,787

$

Total Benefits
$
$
Return Calculations
(Less) Total Project Financial
Costs
(1,614)
Direct$ Benefits
Improvement due to Total Benefits
(1,614) $

66,992

$

(10,830)

ROI
Financial Return Calculations 99%

11,787

$

66,992

$

(10,830)

All Benefits
56,162
$
56,162

22,617
(10,830)
11,787
66,992
(10,830)

$

56,162

489%

IRR

729%
Direct
Benefits

All3479%
Benefits

ROI
NPV

99%
$51,132

489%
$151,454

IRR
Benefit
to Cost

729%
2.0

3479%
5.8

NPV
Payback
Timing

$51,132
6.6
months

$151,454
2.2
months

Benefit to Cost

2.0

5.8

Payback Timing

6.6 months

2.2 months

* Median hourly wages from US Bureau of Labor Statistics used
^Assuming
45%is
increase
in screenings due
project Improvement Financial
*This
tool
an adaptation
of to
Clinical
~Average cost of turnover for a bedside RN from 2020 NSI Nursing Solutions Report

Tool from Brown, B., & Falk, L.
(2013). How to drive ROI in your healthcare improvement projects (Executive Report).
(https://downloads.healthcatalyst.com/wp-content/uploads/2013/11/Executive-Report-DrivingROI-final.pdf) by Health Catalyst, Inc., and is used under license.

70

Appendix K
Gantt Chart for Project Timeline

Start
End
6/20/21
6/20/21
6/21/21
5/15/22
6/20/21
7/10/21
7/11/21
8/25/21
8/25/21
8/31/21
8/31/21
8/31/21
8/31/21 12/31/21
12/15/21 1/15/21
12/15/21
1/5/21
1/15/21
2/20/21
3/1/21
3/15/21
3/15/21
5/15/21

Activity
Proposal Defense
Work with Stakeholders
Develop Policy/Procedure
Expert Panel
Educate Staff
Implement Policy/Procedure
Compliance Audits
Analyze Data
Gather data on other programs
Prepare Presentation/Publication
Present Data and Project
Discuss barriers and next steps

Jun-21

Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21
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Jan-22 Feb-22 Mar-22 Apr-22 May-22

Appendix L
Result Tables
Table 1
Demographics of the Expert Panel
Characteristic
Invited Experts (n=24) Participated Experts (n=9)
Expertise
nurse-driven protocols
10
3
metabolic screening
9
5
empowerment
5
1
Role
nurse
pharmacist
physician
Country
Australia
Belgium
Canada
Singapore
United Kingdom
United States

12
2
9

5
0
4

2
1
5
1
2
8

1
1
4
0
0
3
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Table 2
Acknowledged Participants of the Expert Panel
Name
Christina Mangurian, MD, MAS
Dr. Mehrul Hasnain
Emily Read, RN, PhD
Gin-Liang CHEE / RN, MSc, GradDipMHN, PhD
candidate
Ingrid Gunther Bell, DNP, AGACNP-BC, FNP-C
Lisa Beck – RN, MSN, CNS

Affiliations
UCSF Department of Psychiatry & Behavioral
Sciences
retired
Associate Dean, Associate Professor, University of
New Brunswick, Faculty of Nursing, Moncton
MACMHN, MACN, STTI
Pace University, New York University Langone
Health

Marc De Hert, MD PhD

University Psychiatric Center KU Leuven,
Belgium

Osnat Melamed MD, MSc

Staff Physician, Centre for Addiction and Mental
Health, Toronto, Ontario, Canada and Assistant
Professor, Department of Family and Community
Medicine, University of Toronto, Ontario, Canada

Thomas Blodgett, PhD, APRN, GCNS, AGACNP-BC

Assistant Professor, Duke University School of
Nursing; Nurse Practitioner, Duke Regional
Hospital, Department of Medicine, Division of
Hospital Medicine
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Table 3
Results of Expert Panel

Very
feasible

1.00
(n=8)

Moderately
feasible

100%

Somewhat
feasible

I-CVI

Not at all
feasible

Feasibility

Very
relevant

Moderately
relevant

Protocol Item
IV.1. If a patient is on a standing dose or long-acting injection of an antipsychotic
medication, a metabolic screening must be performed at least once every 12 months,
including baseline results prior to the initiation of an anti-psychotic.

Somewhat
relevant

Not at all
relevant

Relevance

I-CVI

100%

1.00
(n=9)

88%

0.88
(n=8)

V.1. If a patient is ordered a standing dose of antipsychotic medication or a one-time dose
of an antipsychotic long acting injectable, the nurse should check the medical record to
see if all elements of a metabolic screening were performed in the last year (12 months).

11%

89%

1.00
(n=9)

V.2. On admission and the day after admission, the nurse (or designee delegated by a
nurse) will take the patient’s blood pressure and enter it into the EMR*.

11%

89%

1.00
(n=9)

100%

1.00
(n=8)

V.3. On admission, the nurse (or designee delegated by a nurse) will measure the patient’s
height and weight, enter the values into the EMR*, and the EMR* will automatically
calculate the patient’s BMI

13%

88%

1.00
(n=8)

100%

1.00
(n=7)

V.4. If there is no record of the patient having a Lipid Panel or Hemoglobin A1c in the
last 12 months, the nurse will order the needed lab(s) as a compliance-initiated order
under the attending physician in the EMR* as an AM lab for the next day (or if
appropriate timing, the nurse can draw after placing order, if the nurse is competent in
phlebotomy). If the order was previously placed but not completed for any reason, the
nurse will re-order the lab(s) as above. (Records can be from another hospital but must be
within the last 12 months and must be placed in the chart.)

100%

1.00
(n=9)

13%

75%

0.88
(n=8)

V.5. Before any element is obtained, the nurse should instruct the patient on the process,
along with the purpose and importance of the metabolic screening. Nurse should also
educate the patient to fast before lipid panel lab draws in order to obtain more accurate
results.

100%

1.00
(n=9)

38%

63%

1.00
(n=8)
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13%

13%

V.6. The nurse should review and acknowledge results of the four components of the
metabolic screening as they are entered into the EMR*. Once all results are present, a
nurse can determine if the screening is abnormal. Criteria for an abnormal metabolic
screening are attached below.

11%

89%

0.89
(n=9)

1.00
(n=9)

V.7. If an abnormal metabolic screening is found, nursing will place an order for an
internal medicine consult and/or the nurse will inform the treatment team to make a postdischarge appointment with a primary care provider for follow-up.

11%

89%

Criteria for Abnormal Metabolic Screening

17%

83%

Flow Chart for Metabolic Screening Protocol

100%

75

1.00
(n=6)
1.00
(n=7)

25%

14%

86%

1.00
(n=7)

13%

63%

0.75
(n=8)

100%
17%

83%

1.00
(n=5)
1.00
(n=6)

Table 4
Expert Opinions
Agree
Metabolic Screening
Metabolic screening should include blood draws, specifically Lipid Panel and glucose (fasting and/or Hemoglobin A1c.

100%

Metabolic screenings should occur at least yearly (or more frequently) for patients on antipsychotic medications.

100%

Inpatients with abnormal metabolic screenings would benefit from having an inpatient internal medicine consult and/or a postdischarge appointment with a primary care provider.

89%

An independently licensed practitioner is not always needed to determine if a metabolic screening should occur, when a
metabolic screening protocol exists.

88%

Appropriate metabolic screening can help increase medication compliance of antipsychotics.

67%

Nurse-driven protocol
Nurses will be able to understand and implement the protocol.

100%

Nurses will be likely to follow the protocol regularly.

86%

Nurse can examine patient records for components of metabolic screening.
Nurses can draw missing labs without referring to a physician or other independently licensed practitioners when a nurse
determines it is appropriate using a metabolic screening protocol.

100%
71%

Nurses can take a patient’s height and weight and calculate a Body mass index (BMI) without referring to a physician or other
independently licensed practitioners when a nurse determines it is appropriate using a metabolic screening protocol.

100%

Nurses can take a patient’s blood pressure without referring to a physician or other independently licensed practitioners when a
nurse determines it is appropriate using a metabolic screening protocol.

100%

The protocol is safe and does not increase any risk of harm to the patient.

100%
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Nursing Empowerment
The protocol will increase nursing autonomy and/or nursing empowerment.

100%

Nurses will have additional responsibility for metabolic screening and for achieving the goal of better patient outcomes.
Nurses will be satisfied with the protocol.
Patients will be satisfied with the protocol.

100%
100%
86%

Other staff (physicians, pharmacists, case managers, etc) will be satisfied with the protocol.

100%

Agree
Metabolic Screening
Metabolic screening should include blood draws, specifically Lipid Panel and glucose
(fasting and/or Hemoglobin A1c.
Metabolic screenings should occur at least yearly (or more frequently) for patients on
antipsychotic medications.
Inpatients with abnormal metabolic screenings would benefit from having an
inpatient internal medicine consult and/or a post-discharge appointment with a
primary care provider.
An independently licensed practitioner is not always needed to determine if a
metabolic screening should occur, when a metabolic screening protocol exists.
Appropriate metabolic screening can help increase medication compliance of
antipsychotics.
Nurse-driven protocol
Nurses will be able to understand and implement the protocol.
Nurses will be likely to follow the protocol regularly.
Nurse can examine patient records for components of metabolic screening.
Nurses can draw missing labs without referring to a physician or other independently
licensed practitioners when a nurse determines it is appropriate using a metabolic
screening protocol.
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100%
100%

89%
88%
67%

100%
86%
100%

71%

Nurses can take a patient’s height and weight and calculate a Body mass index (BMI)
without referring to a physician or other independently licensed practitioners when a
nurse determines it is appropriate using a metabolic screening protocol.

100%

Nurses can take a patient’s blood pressure without referring to a physician or other
independently licensed practitioners when a nurse determines it is appropriate using a
metabolic screening protocol.
The protocol is safe and does not increase any risk of harm to the patient.

100%
100%

Nursing Empowerment
The protocol will increase nursing autonomy and/or nursing empowerment.
Nurses will have additional responsibility for metabolic screening and for achieving
the goal of better patient outcomes.
Nurses will be satisfied with the protocol.
Patients will be satisfied with the protocol.
Other staff (physicians, pharmacists, case managers, etc) will be satisfied with the
protocol.
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100%
100%
100%
86%
100%

Table 5
Patient Demographics

Demographics

Pre-Intervention
(n=150)

Post-Intervention (n=140)
Time 1 (n=95)

Time 2 (n=45)

Age, mean (SD)
Gender, n (%)
Female
Male
Race, n (%)

36.8 (11.9)

37.6 (12.4)

36.8 (12.3)

73 (48.7%)
77 (51.3%)

47 (49.5%)
48 (50.5%)

18 (40%)
27 (60%)

Black/African American
American Indian/Alaskan Native
White
Other
Asian
Bi-Racial
Antipsychotic Class, n (%)
FGA
SGA
Risk Level, n (%)
Low
Moderate
High

69 (47.3%)
3 (2.1%)
55 (37.7%)
12 (8.2%)
6 (4.1%)
1 (0.7%)

Statistical Analysis

F (2, 287) = .132, p = .877
χ2 (2, N = 290) = 1.244, p = .537

χ2 (10, N = 290) = 3.699, p = .960
52 (55.3%)
1 (1.1%)
33 (35.1%)
5 (5.3%)
2 (2.1%)
1 (1.1%)

25 (55.6%)
1 (2.2%)
14 (31.1%)
3 (6.7%)
2 (4.4%)
0 (0%)
χ2 (2, N = 290) = 4.732, p = .094

28 (18.7%)
122 (81.3%)

15 (15.8%)
80 (84.2%)

14 (31.1%)
31 (68.9%)
χ2 (4, N = 290) = 2.243, p = .691

48 (32.0%)
59 (39.3%)
43 (28.7%)

24 (25.3%)
38 (40.0%)
33 (34.7%)

14 (31.1%)
15 (33.3%)
16 (35.6%)
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Table 6
Metabolic Screening Compliance and Indices

Metabolic Screening

Pre-Intervention
(n=150)

Complete screening, n (%)
Body-Mass Index (BMI)
Blood Pressure
Lipid Panel
Glucose (FBS or HgbA1c)

100 (66.7%)
139 (93.3%)
150 (100%)
112 (74.7%)
135 (90.6%)

Post-Intervention (n=140)

Statistical Analysis

Time 1 (n=95)

Time 2 (n=45)

66 (69.5%)
93 (97.9%)
95 (100%)
69 (72.6%)
92 (96.8%)

40 (88.9%)
42 (93.3%)
45 (100%)
42 (93.3%)
43 (97.7%)

χ2 (2, N = 290) = 8.475, p = .014*
χ2 (2, N = 290) = 2.737, p = .25
χ2 (2, N = 290) = 8.236, p = .016*
χ2 (2, N = 290) = 5.255, p = .072
*Statistical Significance (p < .05)

Table 7
Patient Outcomes of Abnormal Screenings

Patient Outcomes

Total

PreIntervention

Post-Intervention
Time 1

Completed screenings, n
Abnormal screening, n (%)
Follow-up care if Abnormal
screening, n (%)
Follow-up Type
Consult, n (%)
Discharge referral, n (%)

Statistical Analysis

Time 2

206
90

100
39 (39%)

66
33 (50%)

40
18 (45%)

χ2 (2, N = 206) = 1.990, p = .370

39 (43%)

16 (41%)

16 (48.5%)

7 (38.9%)

χ2 (2, N = 90) = 0.586, p = .746

34 (87%)
17 (44%)

15 (93.8%)
6 (37.5%)

13 (81.3%)
10 (62.5%)

6 (85.7%)
1 (14.3%)

χ2 (2, N = 90) = 0.196, p = .907
χ2 (2, N = 90) = 5.207, p = .074
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Table 8
Staff Demographics
Demographics
Employment, n (%)*
Hospital
Agency
Role, n (%)*
Registered nurse (RN)
Licensed Practical Nurses (LPN)
Unit, n (%)
Unit A
Unit B
Age, n (%)**
20-30
30-40
40-50
50-60
60-70 and above
Years of Experience, n (%)**
less than 1 year
1-3 years
4-6 years
7-15 years
15 or more years
Gender, n (%)*
Female
Male
Nursing Education, n (%)**
Associate’s degree or diploma

Pre-Survey
(n=13)

Post-Survey
(n=8)

11 (84.6%)
2 (15.4%)

8 (100%)
0 (0%)

12 (92.3%)
1 (7.7%)

7 (87.5%)
1 (12.5%)

6 (46.2%)
7 (53.8%)

8 (100%)
0 (0%)

3 (23.1%)
5 (38.5%)
3 (23.1%)
1 (7.7%)
1 (7.7%)

3 (37.5%)
2 (25.0%)
0 (0.0%)
2 (25%)
1 (12.5%)

1 (7.7%)
5 (38.5%)
1 (7.7%)
1 (7.7%)
5 (38.5%)

0 (0.0%)
4 (50.0%)
0 (0.0%)
1 (12.5%)
3 (37.5%)

12 (92.3%)
1 (7.7%)

6 (75%)
2 (25%)

4 (30.8%)

2 (25%)
81

Bachelor’s degree
Graduate degree
Psychiatric Nursing Certification, n (%)**

7 (53.8%)
2 (15.4%)
2 (15.4%)

5 (62.5%)
1 (12.5%)
2 (25.0%)

*not significant via Fisher's Exact Test
**not significant via Pearson Chi-Square

Table 9
Psychological Empowerment Scale Scores

Empowerment Survey
Total Score, mean (SD)
Meaning subscore
Competence subscore
Self-Determination subscore
Impact subscore

Pre-Survey
(n=13)

PostSurvey
(n=8)

Statistical
Analysis*

5.72 (0.75) 5.60 (0.64)
p = .718
6.38 (0.76) 6.38 (0.73)
p = .992
5.97 (0.81) 5.95 (0.73)
p = .952
5.89 (0.73) 5.19 (0.98)
p = .130
4.62 (1.08) 4.86 (1.14)
p = .644
*t-test for Equality of Means, two-sided
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Table 10
Close-ended Questions on Nurses’ Perception
Yes Responses from
Post-Survey (n=8)
Did you find the protocol easy to use?

57%

Did you find the protocol helpful in providing care to your patients?
29%
Did you like using the protocol?

43%

Did you find using the protocol empowering?

38%

Do you think the responsibilities under the protocol should fall under the nurse?
Do you think the responsibilities under the protocol should fall under the physician?
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63%
75%

